Correlation Between Viracta Therapeutics and Oculis Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Oculis Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Oculis Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Oculis Holding AG, you can compare the effects of market volatilities on Viracta Therapeutics and Oculis Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Oculis Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Oculis Holding.

Diversification Opportunities for Viracta Therapeutics and Oculis Holding

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Viracta and Oculis is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Oculis Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oculis Holding AG and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Oculis Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oculis Holding AG has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Oculis Holding go up and down completely randomly.

Pair Corralation between Viracta Therapeutics and Oculis Holding

Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Oculis Holding. But the stock apears to be less risky and, when comparing its historical volatility, Viracta Therapeutics is 1.62 times less risky than Oculis Holding. The stock trades about -0.01 of its potential returns per unit of risk. The Oculis Holding AG is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  500.00  in Oculis Holding AG on September 12, 2024 and sell it today you would lose (27.00) from holding Oculis Holding AG or give up 5.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Viracta Therapeutics  vs.  Oculis Holding AG

 Performance 
       Timeline  
Viracta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viracta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Oculis Holding AG 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Oculis Holding AG are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Oculis Holding showed solid returns over the last few months and may actually be approaching a breakup point.

Viracta Therapeutics and Oculis Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viracta Therapeutics and Oculis Holding

The main advantage of trading using opposite Viracta Therapeutics and Oculis Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Oculis Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oculis Holding will offset losses from the drop in Oculis Holding's long position.
The idea behind Viracta Therapeutics and Oculis Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Transaction History
View history of all your transactions and understand their impact on performance